English

AVALON GLOBOCARE CORP.

EDGAR

ALBT Current report (8-K) · filed 2026-10-30

Annual consolidated revenue for 2024: about USD 1.333M, using the latest reported figures. The previous period, 2023, was about USD 1.256M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

350 thousand USD

2025 Q3 · USD

Exact inputs and evidence

Revenue: 350099 USD Source

Operating margin

-21.76%

2025 Q3 · %

Exact inputs and evidence

Operating Income: -76193 USD Source
Revenue: 350099 USD Source

Cash and cash equivalents: 39.2 thousand USD 2026-06-30 Source
Exact value

39221 USD
Long-term debt including current maturities: 67.4 thousand USD 2023-06-30 Source
Exact value

67434 USD
Shares outstanding: 13.7 million shares 2026-06-30 Source
Exact value

13677323 shares

Reported share-count change

482.24% · 11.3 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

2349084 shares · 2025-06-30· Source
13677323 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.4 million USD

2024-10-01 – 2025-09-30

Exact inputs and evidence

Revenue: 1333403 USD · 2024-01-01 – 2024-12-31 Source
Revenue: 987634 USD · 2024-01-01 – 2024-09-30 Source
Revenue: 349800 USD · 2025-01-01 – 2025-03-31 Source
Revenue: 350406 USD · 2025-04-01 – 2025-06-30 Source
Revenue: 350099 USD · 2025-07-01 – 2025-09-30 Source

Net income

-8.98 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -254268 USD · 2025-07-01 – 2025-09-30 Source
Net income: -18260976 USD · 2025-01-01 – 2025-12-31 Source
Net income: -16194977 USD · 2025-01-01 – 2025-09-30 Source
Net income: -4479695 USD · 2026-01-01 – 2026-03-31 Source
Net income: -2178812 USD · 2026-04-01 – 2026-06-30 Source

Capital expenditure

22.2 thousand USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Capital expenditure: 1749 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 1749 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 1749 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 1749 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 20185 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 22201 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 20185 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2024-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2024-12-31
Operating income: 10 of 11 periods available· newest 2024-12-31
Net income: 10 of 11 periods available· newest 2024-12-31
Operating cash flow: 10 of 11 periods available· newest 2024-12-31
Capital expenditure: 5 of 11 periods available· newest 2023-12-31
Total assets: 9 of 11 periods available· newest 2024-12-31
Total liabilities: 8 of 11 periods available· newest 2024-12-31
Current assets: 9 of 11 periods available· newest 2024-12-31
Current liabilities: 9 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2024-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2021-12-31
Shares outstanding: 9 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+6.2%

Prior period

USD 1.26 million

2023-01-01 – 2023-12-31
Current period

USD 1.33 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

1333403 − 1255681 = 77722 USD

1255681 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
1333403 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AVALON GLOBOCARE CORP. · 2024-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Year-over-year change in Revenue: 77722 USD Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1333403 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390025035157/ea0238798-s4_avalon.htm#4890462 Filing: 000121390025035157 Input fundies:Revenue: 1255681 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390025035157/ea0238798-s4_avalon.htm#4902458 Filing: 000121390025035157
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 8.8 million

Prior period

−USD 16.71 million

2023-01-01 – 2023-12-31
Current period

−USD 7.9 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-7903394 − -16707010 = 8803616 USD

-16707010 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-7903394 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AVALON GLOBOCARE CORP. · 2024-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Year-over-year change in Net income: 8803616 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7903394 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390026086806/ea0300078-s1_change.htm#845586 Filing: 000121390026086806 Input fundies:NetIncome: -16707010 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390025035157/ea0238798-s4_avalon.htm#4911758 Filing: 000121390025035157
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.84 million

Prior period

−USD 6.5 million

2023-01-01 – 2023-12-31
Current period

−USD 4.67 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-4668458 − -6504718 = 1836260 USD

-6504718 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-4668458 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AVALON GLOBOCARE CORP. · 2024-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Year-over-year change in Operating cash flow: 1836260 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4668458 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390026086806/ea0300078-s1_change.htm#1292692 Filing: 000121390026086806 Input fundies:OperatingCashFlow: -6504718 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390025035157/ea0238798-s4_avalon.htm#4211797 Filing: 000121390025035157
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue USD 1.33 million 100% of revenue
Operating costs Derived USD 6.17 million 463% of revenue
Operating income −USD 4.84 million −363% of revenue
Tax, interest and other Derived USD 3.06 million 230% of revenue
Net income −USD 7.9 million −593% of revenue

Cash

Operating cash flow −USD 4.67 million −350% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 9%88%
2017 Operating loss: operating costs were 460% of revenue.
2018 Operating loss: operating costs were 588% of revenue.
2019 Operating loss: operating costs were 1,353% of revenue.
2020 Operating loss: operating costs were 1,004% of revenue.
2021 Operating loss: operating costs were 735% of revenue.
2022 Operating loss: operating costs were 346% of revenue.
2023 Operating loss: operating costs were 1,355% of revenue.
2024 Operating loss: operating costs were 463% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	616446	539513 Derived	76933	21352 Derived	55581	13650 Derived	Source 2016-01-01 – 2016-12-31: 616446 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 76933 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 55581 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 13984 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 334 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	1077550	4955413 Derived	-3877863	171782 Derived	-4049645	-1487702 Derived	Source 2017-01-01 – 2017-12-31: 1077550 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -3877863 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -4049645 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -1339692 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 148010 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	1562286	9193421 Derived	-7631135	421161 Derived	-8052296	Unavailable	Source 2018-01-01 – 2018-12-31: 1562286 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -7631135 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -8052296 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -4396024 USD Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	1546305	20923535 Derived	-19377230	-1307069 Derived	-18070161	Unavailable	Source 2019-01-01 – 2019-12-31: 1546305 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -19377230 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -18070161 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -7079871 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	1377762	13831781 Derived	-12454019	225419 Derived	-12679438	Unavailable	Source 2020-01-01 – 2020-12-31: 1377762 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -12454019 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -12679438 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -7546100 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	1390972	10224802 Derived	-8833830	256669 Derived	-9090499	-5041981 Derived	Source 2021-01-01 – 2021-12-31: 1390972 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -8833830 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -9090499 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -5024479 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 17502 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	3576333	12369228 Derived	-8792895	3137952 Derived	-11930847	-7038973 Derived	Source 2022-01-01 – 2022-12-31: 3576333 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -8792895 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -11930847 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -7037224 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 1749 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	1255681	17009364 Derived	-15753683	953327 Derived	-16707010	-6526877 Derived	Source 2023-01-01 – 2023-12-31: 1255681 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -15753683 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -16707010 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -6504718 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 22159 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	1333403	6174653 Derived	-4841250	3062144 Derived	-7903394	Unavailable	Source 2024-01-01 – 2024-12-31: 1333403 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -4841250 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -7903394 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -4668458 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.3M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	616446	Revenue: 616446 Open source
20172017-12-31	Revenue	1077550	Revenue: 1077550 Open source
20182018-12-31	Revenue	1562286	Revenue: 1562286 Open source
20192019-12-31	Revenue	1546305	Revenue: 1546305 Open source
20202020-12-31	Revenue	1377762	Revenue: 1377762 Open source
20212021-12-31	Revenue	1390972	Revenue: 1390972 Open source
20222022-12-31	Revenue	3576333	Revenue: 3576333 Open source
20232023-12-31	Revenue	1255681	Revenue: 1255681 Open source
20242024-12-31	Revenue	1333403	Revenue: 1333403 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

6.2% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 616446 Open source
20172017-12-31	Year over year	74.8%	Revenue: 1077550 Open source Revenue: 616446 Open source
20182018-12-31	Year over year	45%	Revenue: 1562286 Open source Revenue: 1077550 Open source
20192019-12-31	Year over year	-1%	Revenue: 1546305 Open source Revenue: 1562286 Open source
20202020-12-31	Year over year	-10.9%	Revenue: 1377762 Open source Revenue: 1546305 Open source
20212021-12-31	Year over year	1%	Revenue: 1390972 Open source Revenue: 1377762 Open source
20222022-12-31	Year over year	157.1%	Revenue: 3576333 Open source Revenue: 1390972 Open source
20232023-12-31	Year over year	-64.9%	Revenue: 1255681 Open source Revenue: 3576333 Open source
20242024-12-31	Year over year	6.2%	Revenue: 1333403 Open source Revenue: 1255681 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -363.1% 2024

Net margin -592.7% 2024

Free cash flow margin -519.8% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	12.5%	Operating Income: 76933 Open source Revenue: 616446 Open source
20172017-12-31	Operating margin	-359.9%	Operating Income: -3877863 Open source Revenue: 1077550 Open source
20182018-12-31	Operating margin	-488.5%	Operating Income: -7631135 Open source Revenue: 1562286 Open source
20192019-12-31	Operating margin	-1,253.1%	Operating Income: -19377230 Open source Revenue: 1546305 Open source
20202020-12-31	Operating margin	-903.9%	Operating Income: -12454019 Open source Revenue: 1377762 Open source
20212021-12-31	Operating margin	-635.1%	Operating Income: -8833830 Open source Revenue: 1390972 Open source
20222022-12-31	Operating margin	-245.9%	Operating Income: -8792895 Open source Revenue: 3576333 Open source
20232023-12-31	Operating margin	-1,254.6%	Operating Income: -15753683 Open source Revenue: 1255681 Open source
20242024-12-31	Operating margin	-363.1%	Operating Income: -4841250 Open source Revenue: 1333403 Open source
20162016-12-31	Net margin	9%	Net Income: 55581 Open source Revenue: 616446 Open source
20172017-12-31	Net margin	-375.8%	Net Income: -4049645 Open source Revenue: 1077550 Open source
20182018-12-31	Net margin	-515.4%	Net Income: -8052296 Open source Revenue: 1562286 Open source
20192019-12-31	Net margin	-1,168.6%	Net Income: -18070161 Open source Revenue: 1546305 Open source
20202020-12-31	Net margin	-920.3%	Net Income: -12679438 Open source Revenue: 1377762 Open source
20212021-12-31	Net margin	-653.5%	Net Income: -9090499 Open source Revenue: 1390972 Open source
20222022-12-31	Net margin	-333.6%	Net Income: -11930847 Open source Revenue: 3576333 Open source
20232023-12-31	Net margin	-1,330.5%	Net Income: -16707010 Open source Revenue: 1255681 Open source
20242024-12-31	Net margin	-592.7%	Net Income: -7903394 Open source Revenue: 1333403 Open source
20162016-12-31	Free cash flow margin	2.2%	Revenue: 616446 Open source Operating Cash Flow: 13984 Open source Capital Expenditure: 334 Open source
20172017-12-31	Free cash flow margin	-138.1%	Revenue: 1077550 Open source Operating Cash Flow: -1339692 Open source Capital Expenditure: 148010 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 1562286 Open source Operating Cash Flow: -4396024 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 1546305 Open source Operating Cash Flow: -7079871 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 1377762 Open source Operating Cash Flow: -7546100 Open source
20212021-12-31	Free cash flow margin	-362.5%	Revenue: 1390972 Open source Operating Cash Flow: -5024479 Open source Capital Expenditure: 17502 Open source
20222022-12-31	Free cash flow margin	-196.8%	Revenue: 3576333 Open source Operating Cash Flow: -7037224 Open source Capital Expenditure: 1749 Open source
20232023-12-31	Free cash flow margin	-519.8%	Revenue: 1255681 Open source Operating Cash Flow: -6504718 Open source Capital Expenditure: 22159 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 1333403 Open source Operating Cash Flow: -4668458 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4.7M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	13984	Operating Cash Flow: 13984 Open source
20172017-12-31	Operating cash flow	-1339692	Operating Cash Flow: -1339692 Open source
20182018-12-31	Operating cash flow	-4396024	Operating Cash Flow: -4396024 Open source
20192019-12-31	Operating cash flow	-7079871	Operating Cash Flow: -7079871 Open source
20202020-12-31	Operating cash flow	-7546100	Operating Cash Flow: -7546100 Open source
20212021-12-31	Operating cash flow	-5024479	Operating Cash Flow: -5024479 Open source
20222022-12-31	Operating cash flow	-7037224	Operating Cash Flow: -7037224 Open source
20232023-12-31	Operating cash flow	-6504718	Operating Cash Flow: -6504718 Open source
20242024-12-31	Operating cash flow	-4668458	Operating Cash Flow: -4668458 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6.5M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	13650	Operating Cash Flow: 13984 Open source Capital Expenditure: 334 Open source
20172017-12-31	Free cash flow	-1487702	Operating Cash Flow: -1339692 Open source Capital Expenditure: 148010 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4396024 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7079871 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7546100 Open source
20212021-12-31	Free cash flow	-5041981	Operating Cash Flow: -5024479 Open source Capital Expenditure: 17502 Open source
20222022-12-31	Free cash flow	-7038973	Operating Cash Flow: -7037224 Open source Capital Expenditure: 1749 Open source
20232023-12-31	Free cash flow	-6526877	Operating Cash Flow: -6504718 Open source Capital Expenditure: 22159 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4668458 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

66.2% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Liabilities / assets	Not reported	Total Assets: 3706508 Open source
20172017-12-31	Liabilities / assets	42.3%	Total Liabilities: 5360184 Open source Total Assets: 12669033 Open source
20182018-12-31	Liabilities / assets	16%	Total Liabilities: 2141720 Open source Total Assets: 13395723 Open source
20192019-12-31	Liabilities / assets	57.4%	Total Liabilities: 6025463 Open source Total Assets: 10490536 Open source
20202020-12-31	Liabilities / assets	60.3%	Total Liabilities: 6249347 Open source Total Assets: 10366266 Open source
20212021-12-31	Liabilities / assets	69.9%	Total Liabilities: 7157821 Open source Total Assets: 10242216 Open source
20222022-12-31	Liabilities / assets	43.5%	Total Liabilities: 8592957 Open source Total Assets: 19751905 Open source
20232023-12-31	Liabilities / assets	64.2%	Total Liabilities: 13213760 Open source Total Assets: 20582536 Open source
20242024-12-31	Liabilities / assets	66.2%	Total Liabilities: 13882555 Open source Total Assets: 20985178 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.23× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	23.12×	Current Assets: 3706213 Open source Current Liabilities: 160317 Open source
20172017-12-31	Current assets / current liabilities	0.6×	Current Assets: 3234977 Open source Current Liabilities: 5360184 Open source
20182018-12-31	Current assets / current liabilities	3.18×	Current Assets: 3625432 Open source Current Liabilities: 1141720 Open source
20192019-12-31	Current assets / current liabilities	0.55×	Current Assets: 1571095 Open source Current Liabilities: 2835463 Open source
20202020-12-31	Current assets / current liabilities	0.5×	Current Assets: 1286337 Open source Current Liabilities: 2592393 Open source
20212021-12-31	Current assets / current liabilities	0.3×	Current Assets: 1323042 Open source Current Liabilities: 4401658 Open source
20222022-12-31	Current assets / current liabilities	0.66×	Current Assets: 2373526 Open source Current Liabilities: 3579805 Open source
20232023-12-31	Current assets / current liabilities	0.13×	Current Assets: 850867 Open source Current Liabilities: 6762686 Open source
20242024-12-31	Current assets / current liabilities	0.23×	Current Assets: 3236498 Open source Current Liabilities: 13882555 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 31,006 Exact value Exact value: -31006 USD 2015-01-01 – 2015-12-31: -31006 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2015-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: -31006 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31006 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000155889116000231/glbl-20160630.xml#18701 Filing: 000155889116000231 The citation records this snapshot. The page link may show a newer release later.	−USD 30,106 Exact value Exact value: -30106 USD 2015-01-01 – 2015-12-31: -30106 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2015-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: -30106 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30106 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000155889116000191/glbl-20151231.xml#32023 Filing: 000155889116000191 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	USD 55,581 Exact value Exact value: 55581 USD 2016-01-01 – 2016-12-31: 55581 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2016-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: 55581 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 55581 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000161577418001839/avco-20171231.xml#100750 Filing: 000161577418001839 The citation records this snapshot. The page link may show a newer release later.	USD 13,984 Exact value Exact value: 13984 USD 2016-01-01 – 2016-12-31: 13984 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2016-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: 13984 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 13984 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000161577418001839/avco-20171231.xml#105622 Filing: 000161577418001839 The citation records this snapshot. The page link may show a newer release later.	USD 334 Exact value Exact value: 334 USD 2016-01-01 – 2016-12-31: 334 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON GLOBOCARE CORP. · 2016-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Capital Expenditure: 334 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 334 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000161577417001269/avco-20161231.xml#215754 Filing: 000161577417001269 The citation records this snapshot. The page link may show a newer release later.	USD 13,650 Calculation and evidence 13984 − 334 USD Exact free cash flow: 13650 USD 2016-01-01 – 2016-12-31: 13984 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 334 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON GLOBOCARE CORP. · 2016-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Free cash flow: 13650 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 13984 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000161577418001839/avco-20171231.xml#105622 Filing: 000161577418001839 Input fundies:CapitalExpenditure: 334 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000161577417001269/avco-20161231.xml#215754 Filing: 000161577417001269 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 4.05 million Exact value Exact value: -4049645 USD 2017-01-01 – 2017-12-31: -4049645 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2017-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: -4049645 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4049645 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390019004862/avco-20181231.xml#184271 Filing: 000121390019004862 The citation records this snapshot. The page link may show a newer release later.	−USD 1.34 million Exact value Exact value: -1339692 USD 2017-01-01 – 2017-12-31: -1339692 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2017-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: -1339692 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1339692 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390019004862/avco-20181231.xml#336058 Filing: 000121390019004862 The citation records this snapshot. The page link may show a newer release later.	USD 148,010 Exact value Exact value: 148010 USD 2017-01-01 – 2017-12-31: 148010 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON GLOBOCARE CORP. · 2017-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Capital Expenditure: 148010 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 148010 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390019004862/avco-20181231.xml#344163 Filing: 000121390019004862 The citation records this snapshot. The page link may show a newer release later.	−USD 1.49 million Calculation and evidence -1339692 − 148010 USD Exact free cash flow: -1487702 USD 2017-01-01 – 2017-12-31: -1339692 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 148010 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON GLOBOCARE CORP. · 2017-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Free cash flow: -1487702 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1339692 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390019004862/avco-20181231.xml#336058 Filing: 000121390019004862 Input fundies:CapitalExpenditure: 148010 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390019004862/avco-20181231.xml#344163 Filing: 000121390019004862 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 8.05 million Exact value Exact value: -8052296 USD 2018-01-01 – 2018-12-31: -8052296 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2018-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: -8052296 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8052296 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390020008655/avco-20191231.xml#169034 Filing: 000121390020008655 The citation records this snapshot. The page link may show a newer release later.	−USD 4.4 million Exact value Exact value: -4396024 USD 2018-01-01 – 2018-12-31: -4396024 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2018-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: -4396024 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4396024 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390020008655/avco-20191231.xml#341212 Filing: 000121390020008655 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 18.07 million Exact value Exact value: -18070161 USD 2019-01-01 – 2019-12-31: -18070161 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2019-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: -18070161 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18070161 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390021018744/avco-20201231.xml#119965 Filing: 000121390021018744 The citation records this snapshot. The page link may show a newer release later.	−USD 7.08 million Exact value Exact value: -7079871 USD 2019-01-01 – 2019-12-31: -7079871 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2019-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: -7079871 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7079871 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390021018744/avco-20201231.xml#141030 Filing: 000121390021018744 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 12.68 million Exact value Exact value: -12679438 USD 2020-01-01 – 2020-12-31: -12679438 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2020-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: -12679438 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12679438 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390022016231/f10k2021_avalonglob.htm#1350816 Filing: 000121390022016231 The citation records this snapshot. The page link may show a newer release later.	−USD 7.55 million Exact value Exact value: -7546100 USD 2020-01-01 – 2020-12-31: -7546100 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2020-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: -7546100 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7546100 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390022016231/f10k2021_avalonglob.htm#1377083 Filing: 000121390022016231 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 9.09 million Exact value Exact value: -9090499 USD 2021-01-01 – 2021-12-31: -9090499 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2021-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: -9090499 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9090499 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390023024687/f10k2022_avalonglob.htm#1123431 Filing: 000121390023024687 The citation records this snapshot. The page link may show a newer release later.	−USD 5.02 million Exact value Exact value: -5024479 USD 2021-01-01 – 2021-12-31: -5024479 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2021-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: -5024479 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5024479 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390023024687/f10k2022_avalonglob.htm#1140291 Filing: 000121390023024687 The citation records this snapshot. The page link may show a newer release later.	USD 17,502 Exact value Exact value: 17502 USD 2021-01-01 – 2021-12-31: 17502 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON GLOBOCARE CORP. · 2021-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Capital Expenditure: 17502 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17502 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390023024687/f10k2022_avalonglob.htm#1141866 Filing: 000121390023024687 The citation records this snapshot. The page link may show a newer release later.	−USD 5.04 million Calculation and evidence -5024479 − 17502 USD Exact free cash flow: -5041981 USD 2021-01-01 – 2021-12-31: -5024479 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 17502 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON GLOBOCARE CORP. · 2021-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Free cash flow: -5041981 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5024479 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390023024687/f10k2022_avalonglob.htm#1140291 Filing: 000121390023024687 Input fundies:CapitalExpenditure: 17502 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390023024687/f10k2022_avalonglob.htm#1141866 Filing: 000121390023024687 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 11.93 million Exact value Exact value: -11930847 USD 2022-01-01 – 2022-12-31: -11930847 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2022-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: -11930847 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11930847 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390024033023/ea0202604-10k_avalon.htm#1910228 Filing: 000121390024033023 The citation records this snapshot. The page link may show a newer release later.	−USD 7.04 million Exact value Exact value: -7037224 USD 2022-01-01 – 2022-12-31: -7037224 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2022-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: -7037224 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7037224 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390024033023/ea0202604-10k_avalon.htm#1295587 Filing: 000121390024033023 The citation records this snapshot. The page link may show a newer release later.	USD 1,749 Exact value Exact value: 1749 USD 2022-01-01 – 2022-12-31: 1749 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON GLOBOCARE CORP. · 2022-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Capital Expenditure: 1749 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1749 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390024033023/ea0202604-10k_avalon.htm#1297276 Filing: 000121390024033023 The citation records this snapshot. The page link may show a newer release later.	−USD 7.04 million Calculation and evidence -7037224 − 1749 USD Exact free cash flow: -7038973 USD 2022-01-01 – 2022-12-31: -7037224 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1749 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON GLOBOCARE CORP. · 2022-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Free cash flow: -7038973 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7037224 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390024033023/ea0202604-10k_avalon.htm#1295587 Filing: 000121390024033023 Input fundies:CapitalExpenditure: 1749 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390024033023/ea0202604-10k_avalon.htm#1297276 Filing: 000121390024033023 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 16.71 million Exact value Exact value: -16707010 USD 2023-01-01 – 2023-12-31: -16707010 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2023-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: -16707010 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16707010 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390025035157/ea0238798-s4_avalon.htm#4911758 Filing: 000121390025035157 The citation records this snapshot. The page link may show a newer release later.	−USD 6.5 million Exact value Exact value: -6504718 USD 2023-01-01 – 2023-12-31: -6504718 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2023-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: -6504718 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6504718 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390025035157/ea0238798-s4_avalon.htm#4211797 Filing: 000121390025035157 The citation records this snapshot. The page link may show a newer release later.	USD 22,159 Exact value Exact value: 22159 USD 2023-01-01 – 2023-12-31: 22159 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AVALON GLOBOCARE CORP. · 2023-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Capital Expenditure: 22159 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22159 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390025035157/ea0238798-s4_avalon.htm#4213326 Filing: 000121390025035157 The citation records this snapshot. The page link may show a newer release later.	−USD 6.53 million Calculation and evidence -6504718 − 22159 USD Exact free cash flow: -6526877 USD 2023-01-01 – 2023-12-31: -6504718 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 22159 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AVALON GLOBOCARE CORP. · 2023-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Free cash flow: -6526877 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6504718 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390025035157/ea0238798-s4_avalon.htm#4211797 Filing: 000121390025035157 Input fundies:CapitalExpenditure: 22159 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390025035157/ea0238798-s4_avalon.htm#4213326 Filing: 000121390025035157 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 7.9 million Exact value Exact value: -7903394 USD 2024-01-01 – 2024-12-31: -7903394 USD Inspect Net Income Open source Share or cite Citation for Net Income · AVALON GLOBOCARE CORP. · 2024-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Net Income: -7903394 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7903394 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390026086806/ea0300078-s1_change.htm#845586 Filing: 000121390026086806 The citation records this snapshot. The page link may show a newer release later.	−USD 4.67 million Exact value Exact value: -4668458 USD 2024-01-01 – 2024-12-31: -4668458 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AVALON GLOBOCARE CORP. · 2024-12-31 AVALON GLOBOCARE CORP. (edgar:1630212) Operating Cash Flow: -4668458 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:39Z Snapshot: 9c510a2e98a036ed9c187dd3c974f819209727c9429a7dcfff98cf64c937e380 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1630212/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4668458 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1630212/000121390026086806/ea0300078-s1_change.htm#1292692 Filing: 000121390026086806 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

76 filings · 3,219 latest values · 3,219 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001630212, 1630212, ALBT, AVCO, CHGA, GTHCD, avco, edgar:1630212

Also known as AVALON GLOBOCARE CORP., Avalon GloboCare Corp., Avalon Globocare Corp., CHANGE AGENTS CORPORATION, Change Agents Corporation, Change Agents Corporation., GLOBAL TECHNOLOGIES CORP

AVALON GLOBOCARE CORP.

Latest quarter

Revenue

Operating margin

Reported share-count change

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation